CD274 and lung cancer: Checkpoint receptor blockade with anti-PD-1 or anti-PD-L1 mAbs enhances murine CAR-T tumor immunity in mouse models [127–129] and human CAR-T immunity against human lung cancer xenografts in NSG mice [130].